Ethambutol is used as an anti-tuberculosis drug at a normal dose of 15-25 mg/kg body weight once every 24 hours. One of its adverse drug reactions is optic neuropathy, which can cause loss of vision and is both dose-dependent and related to the duration of treatment. Vision loss typically does not occur until at least 2 months of treatment and is more common in patients receiving daily doses of 25 mg/kg or higher, though some cases have been reported at lower doses as well.
Ethambutol is used as an anti-tuberculosis drug at a normal dose of 15-25 mg/kg body weight once every 24 hours. One of its adverse drug reactions is optic neuropathy, which can cause loss of vision and is both dose-dependent and related to the duration of treatment. Vision loss typically does not occur until at least 2 months of treatment and is more common in patients receiving daily doses of 25 mg/kg or higher, though some cases have been reported at lower doses as well.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPTX, PDF, TXT or read online from Scribd
Ethambutol is used as an anti-tuberculosis drug at a normal dose of 15-25 mg/kg body weight once every 24 hours. One of its adverse drug reactions is optic neuropathy, which can cause loss of vision and is both dose-dependent and related to the duration of treatment. Vision loss typically does not occur until at least 2 months of treatment and is more common in patients receiving daily doses of 25 mg/kg or higher, though some cases have been reported at lower doses as well.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPTX, PDF, TXT or read online from Scribd
every 24 hours 10 DACANAY, Christopher Rey L. Adverse Drug Reaction Optic Neuropathy - dose dependent and duration related - Ethambutol alters the synaptic connections in the retina and induces morphologic alterations on the same area -Loss of vision does not tend to occur until the patient has been on the drug for at least 2 months - The toxicity that can occur to the anterior visual pathway from this drug is dose related; patients who are receiving dosages of 25 mg/kg/d or greater are most susceptible to vision loss. However, cases of vision loss, even with much lower doses, have been reported.
- Symptoms: Low Visual acuity, loss of vision, red-green color blindness
Source: Kintanar et al. (1996), Adverse Drug Reactions: Guide to Participating Hospitals. Excel Printing: Manila Optic Neuropathy by ETHAMBUTOL
Dr. Rajendra Prasad Koduri Specialist - Dept. of Anesthesia Mafraq Hospital. Review Article From The European Journal of Anesthesiology-EJA September 2008